June 12, 2021 10:55 am
Disposes of plea after state govt assurance that adequate security will be provided to SII CEO on his India return
May 04, 2021 10:56 am
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
April 25, 2021 8:39 am
This, despite it being contract-manufactured by Pune’s Serum Institute of India whose CEO Adar Poonawalla had said that the firm was making a profit even at a price of Rs 150 per dose.
January 17, 2021 4:26 am
Poonawalla took to Twitter and posted a video which showed that he was injected with the vaccine
November 05, 2020 11:07 am
Adar Poonawalla, CEO of SII said preliminary results have shown that there are no immediate concerns pertaining to the Covishield vaccine. A total of 1600 people have been administered the first dose across 17 sites, and each participant is being followed up for six months to ensure safety of the vaccine.
October 28, 2020 9:07 pm
"If we don't go for an emergency license, our trials should be over by December and then we can maybe we can launch in India in January subject to the UK trial, which is on the verge of being completed," Adar Poonawalla said.
September 28, 2020 9:12 am
Serum Institute of India has the licence to produce and market two of the leading vaccine candidates, one being developed by AstraZeneca and the Oxford University, and the other one by US company Novavax.